Form D · Biotechnology
AutoGenomics, Inc.
Vista, CA · CIK 0001439210
Offering snapshot reported Jan 11, 2013 · SEC filing
- Reported sold
- $166K Offering amount: $166K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 27, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 11, 2013 | Initial | $165,600 | No comparison | 1 | SEC filing |
| Jul 14, 2010 | Initial | $8,576,800 | No comparison | 30 | SEC filing |
| Jul 8, 2010 | Initial | $20,000 | No comparison | 2 | SEC filing |
| Jul 8, 2010 | Initial | $100,000 | No comparison | 3 | SEC filing |
| Jul 8, 2010 | Amendment | $17,632,595 | $11,159,117vs Jun 8, 2010 | 67 | SEC filing |
| Jul 7, 2010 | Initial | $5,054,117 | No comparison | 60 | SEC filing |
| Jun 8, 2010 | Initial | $274,000 | No comparison | 1 | SEC filing |
| Jun 8, 2010 | Initial | $11,125,589 | No comparison | 50 | SEC filing |
| Jun 8, 2010 | Initial | $6,473,478 | No comparison | 14 | SEC filing |
| Jun 8, 2010 | Initial | $30,000 | No comparison | 1 | SEC filing |
| Jun 8, 2010 | Initial | $75,000 | No comparison | 1 | SEC filing |
| Jun 3, 2010 | Initial | $1,121,400 | No comparison | 5 | SEC filing |
| Jun 2, 2010 | Initial | $14,111,640 | No comparison | 23 | SEC filing |
| Jun 2, 2010 | Initial | $10,751,014 | No comparison | 2 | SEC filing |
| Mar 25, 2010 | Initial | $13,125,000 | No comparison | 18 | SEC filing |
| Mar 25, 2010 | Amendment | $13,125,000 | $0vs Mar 25, 2010 | 18 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 04
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-190067
Source: Form D, filed Jan 11, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Stephen Allison | Director |
| Charles Birmingham | Director |
| Nanibhushan Dattagupta, Ph.D. | Executive |
| William H. Davidson, D.B.A. | Director |
| Laurence M. Demers | Director |
| Laurence M. Demers, Ph.D. | Director |
| Patrick Dillon | Executive |
| Thomas V. Hennessey, Jr. | Director, Executive |
| Eric S. Kentor | Director |
| Fareed Kureshy | Director, Executive |
| Randall R. Lunn | Director |
| Donald E. Pogorzelski | Director |
| Shailendra Singh | Executive |
| Shailendra Singh, Ph.D. | Executive |
| Joseph P. Sullivan | Director |
| Thomas R. Testman | Director |
| Ramanath Vairavan | Executive |
| Peter Wilding | Director |
| Eugene J. Zurlo | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2980 Scott Street
Vista, CA, 92081
Vista, CA, 92081